Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc.
GLENDALE, Calif., June 30 /PRNewswire/ -- If you have been eating Garlic to keep the mosquitoes away you may want to think again. While there is absolutely no scientific evidence that eating garlic actually keeps mosquitoes away, spraying garlic has plenty of evidence to prove it keeps them away....
Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
CHICAGO, June 15 /PRNewswire-USNewswire/ -- Body mass index (BMI) should be taken into account when assessing a cancer patient's vitamin D status, according to researchers at Cancer Treatment Centers of America (CTCA), who found that obese cancer patients had significantly lower levels of vita...
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Novo Nordisk (NVO) data presented today at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sug...
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
- Oral presentation on Sandostatin(R) LAR Depot Phase III data shows significant antitumor benefit in patients with advanced neuroendocrine tumors of the midgut
- Early data show that at eight weeks of treatment, Afinitor(R) stabilized or reduced tumor size in 61% of patients with advanced...
Getting More From Whole-Transcript Microarrays
MELBOURNE, Australia , May 22 /PRNewswire/ -- The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing. Research published today in the open access journal BMC Bioi...
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease
NATICK, Mass. and BARCELONA, Spain, May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that percutaneous coronary ...
Chronic Ankle Pain May Be More Than Just a Sprain
New information indicates tendon injuries may be the culprit
ROSEMONT, Ill., May 1 /PRNewswire-USNewswire/ -- Ankle sprains are a common injury after a fall, sudden twist or blow to the ankle joint.
Approximately 40 percent of those who suffer an ankle sprain will e...
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease
NATICK, Mass. and ORLANDO, Fla., March 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that while the overall cost ...
New Proton Therapy Equipment Enables More Tumors to be Treated
JACKSONVILLE, Fla. Feb. 23 /PRNewswire/ -- An advance in the way protons are delivered at the University of Florida Proton Therapy Institute enables physicians to treat tumors that are deeper in the body, tumors that are very large and tumors that are situated closer to vital organs.
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
REYKJAVIK, Iceland, Feb. 6 /PRNewswire-FirstCall/ -- Scientists at deCODE
genetics (Nasdaq: DCGN ) today present the discovery of two single letter
variations in the sequence of the human genome (SNPs) conferring substantial
increased risk of thyroid cancer. The two SNPs, located on chromoso...
St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment
Scan of thousands of inherited genetic changes reveal specific variations linked to treatment failure and the fate of chemotherapy drugs in the body for children with acute lymphoblastic leukemia
MEMPHIS, Tenn., Jan. 27 /PRNewswire-USNewswire/ -- Scientists from St. Jude Children's Research H...
Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TV's 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol
SAN DIMAS, Calif., Jan. 25 /PRNewswire/ -- A red wine resveratrol (rez-vair-ah-trawl) pill is edging closer to being confirmed as an anti-aging pill as researchers at LifeGen Technologies in Madison, Wisconsin, who were recently interviewed on CBS-TV's 60 MINUTES, reported this past September that...
RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
- After eight weeks of treatment, RAD001 halted tumor growth in 55% of advanced gastric cancer patients previously treated with chemotherapy
- Based on these promising data, Novartis will initiate a Phase III trial of RAD001 for advanced gastric cancer patients
- Gastric cancer is the s...
Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months
SEATTLE, Dec. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
(Nasdaq and MTA: CTIC) announced today that extended follow-up data for the
Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line Indolent (FIT) study
presented at the American Society of Hematology (ASH) 50th Annual Meeting by
Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
SAN FRANCISCO, Oct. 15 /PRNewswire-USNewswire/ -- In a national study
presented earlier today at the 2008 American College of Surgeons (ACS)
Clinical Congress, a researcher reported that "women under 40 years of age
diagnosed with Stage I breast cancer are 44 percent more
likely to die than
St. Jude Study Finds Treatment With New Drug Might Make Tumor Cells More Sensitive to Therapy
Study shows treatment with a newly discovered drug could be useful in
sensitizing tumor cells to therapeutic irradiation and potentially some
MEMPHIS, Tenn., Sept. 16 /PRNewswire-USNewswire/ -- Scientists at St.
Jude Children's Research Hospital have shown that it might be pos...
New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence
Results add to body of clinical evidence demonstrating the efficacy and safety of synthetic mesh slings for treatment of stress urinary incontinence in women.
SOMERVILLE, N.J., Sept. 8 /PRNewswire/ -- A new study published in the
August issue of International Urogyne...
Shingles Pain Treatment Will Benefit More Patients
LONDON, August 21 /PRNewswire/ -- The medicated pain relief plaster,
(Versatis) is now approved by the Scottish Medicines Consortium (SMC) for
restricted use within NHS Scotland for patients suffering pain following
shingles(1) http://www.scottishmedicines.org.uk/smc/5850.html . This
Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
SAN DIEGO, July 21 /PRNewswire/ -- Bioimpedance spectroscopy (BIS) is
more accurate and reliable than other methods of subclinical assessment of
lymphedema in breast cancer patients, according to a paper published in the
July 20 issue of Journal of Clinical Oncology (2008; Vol. 26, Issue 21:
New Data Demonstrates 5-FU Personalized Chemotherapy Management (PCM(R)) Assay Provides Similar Performance to More Complicated Liquid Chromatography-Mass Spectrometry (LC-MS/MS)
BETHLEHEM, Pa., June 23 /PRNewswire/ -- A new blood test may make it
easier for oncologists to accurately measure and personalize 5-fluorouracil
(5-FU) dosing for patients undergoing continuous infusion chemotherapy
regimens. Data from a multicenter trial showed that a nanoparticle-based
Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Halozyme Therapeutics,
Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and
commercializing products targeting the extracellular matrix, today
announced new Phase I data for the company's diabetes mellitus program at
the American Dia...
Women Who Gain Excessive Weight During Pregnancy More Likely to Have Overweight Children
PHILADELPHIA, June 9 /PRNewswire-USNewswire/ -- Children of mothers who
than the recommended amount of weight during pregnancy are more
likely to be overweight at age seven, say researchers from The Children's
Hospital of Philadelphia and the University of Pennsylvania School of
Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
ROCHESTER, Minn., June 4 /PRNewswire-USNewswire/ -- People recovering
from acute heart problems such as heart attack and heart surgery are more
likely to develop habits to control heart attack risk factors when they
meet regularly with cardiac "disease managers," according to researchers at
Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon
- Tolerability is an Increasingly Important Factor When Selecting Treatment Options for Patients - ABSTRACT No: 5110 (Poster 6H)
BASEL, Switzerland, May 30 /PRNewswire/ -- Data presented at the
largest oncology meeting in the world, the American Societ...
Discovering How Video Games Can Motivate Healthy Behaviors: More than $2 Million Awarded to 12 Research Teams Across U.S.
Awards go to researchers in CA, FL, IN, ME, NC, NY, SC, VT and WA;
Studies explore how games can increase physical activity and enhance
prevention, self-management of health conditions
PRINCETON, N.J., May 29 /PRNewswire-USNewswire/ -- The Robert Wood
Johnson Foundation (RWJF) announced today...
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Placebo-Controlled Study Results Published in May 20 Issue of Neurology
WOODCLIFF LAKE, N.J., May 20 /PRNewswire/ -- Eisai Corporation of North
America announced today the publication of a placebo-controlled study in
Neurology that found patients with Lennox-Gastaut syndrome (LGS) treated
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
- RECORD-1 trial shows RAD001 reduces risk of disease progression by 70%
- RAD001 is first and only drug to show significant benefit after failure
of approved therapies Sutent(R) or Nexavar(R),** with potential to address unmet medical need
- Once-daily oral RAD001 di...
Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
- Unprecedented amount of research reflects depth and breadth of
collaboration with investigators worldwide to develop new treatments for diverse forms of cancer - Plenary session to highlight impact of Zometa(R), the leading IV
bisphosphonate, on relapse rate of ...
Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits
HONOLULU, May 5 /PRNewswire/ -- Research presented at the annual
meeting of the Pediatric Academic Societies (PAS) shows that by starting
flu vaccinations in August -- ahead of the start of the typical flu
vaccination season -- healthcare providers could reach an additional 10.7
Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate
Dr. Gregory Ellison, Director of Advanced Medical Center, Licensed to Administer PROMETA(R)
PHOENIX, April 11 /PRNewswire/ -- With Arizona facing a critical crisis
of methamphetamine use, Dr. Gregory Ellison, Director of Advanced Medical
Center, has identified a very p...
The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude
First-ever Radio One/St. Jude Radiothon reached listeners in nine
cities across the United States
MEMPHIS, Tenn., April 10 /PRNewswire-USNewswire/ -- The Yolanda Adams
Morning Show and nine Radio One gospel radio stations raised $1,015,773
during the first-ever Radio One/St. Jude Radi...
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Reductions seen as soon as three days and out to 450 days in patients who received either bare metal or drug-eluting stents
CHICAGO, March 29 /PRNewswire-FirstCall/ -- The investigational
antiplatelet drug prasugrel plus aspirin produced a marked and highly
statistically significant r...
Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
UPPSALA, Sweden, and WILMINGTON, Mass., March 28 /PRNewswire/ -- Use of
a low profile PressureWire yields a more
accurate assessment of translesion
pressure gradients when compared to catheter-derived pressure gradient
(CPG) measurements, according to a paper published in the Journal of
Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
Self-testing could assist physicians in achieving better outcomes for AF, venous thromboembolism patients
INDIANAPOLIS, March 19 /PRNewswire/ -- Medicare Part B will now cover
and pay for meter training, equipment and supplies for all long-term
warfarin users who monitor thei...
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
New study results also demonstrate the longest duration of consistently high antibody levels shown by a cervical cancer vaccine
TAMPA, Fla., March 10 /PRNewswire-FirstCall/ -- New data demonstrate
that GlaxoSmithKline's (NYSE: GSK ) cervical cancer candidate vaccine,
Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
Distinguished Physicians' Panel at American Venous Forum Presents Clinical
Trial Results Confirming Efficacy, Greater Patient Comfort Than Laser
SAN JOSE, Calif., Feb. 23 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS ), a worldwide leader in medical devices
Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
MELBOURNE, Australia, Feb. 15 /PRNewswire/ -- In a landmark study
electronically published today in the American Journal of Respiratory and
Critical Care Medicine, a blood test for detecting TB infection,
QuantiFERON(R)-TB Gold (QFT(TM)), has been shown to be six times more
accurate than the c...
RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial
- CLINICAL TRIAL RESULTS PUBLISHED IN THE JOURNAL OF DERMATOLOGIC SURGERY -
SAN MATEO, Calif., Jan. 14 /PRNewswire-FirstCall/ -- BioForm Medical,
Inc. (Nasdaq: BFRM ) today announced the publication of a post-marketing
multi- center, randomized, blinded comparative study of nasolabial fold
New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia
KENILWORTH, N.J., Dec. 17 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP ) today reported on new study results that
demonstrated that Asenapine, a fast-dissolving, sublingual tablet being
developed for treatment of schizophrenia, was more
effective than placebo
and well tole...
LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
Observational study published in the Annals of Surgery
MELBOURNE, Australia, Nov. 21 /PRNewswire/ -- Severely obese people who
received the LAP-BAND(R) Adjustable Gastric Banding System to lose weight
had a 72 percent reduction in their risk of dying compared to obese people
who were ...